Lonza and Sartorius Stedim Biotech (Sartorius) have modified their current agreement for supply of cell culture media by mutual accord. The agreement, signed in 2012, gave Sartorius exclusive sales and marketing rights for certain media and buffers developed and manufactured by Lonza for use in biopharmaceutical manufacturing processes. Lonza retained sales for research-based products, among…

Capsule Delivery Solutions, part of Lonza Pharma & Biotech, is launching Capsugel Colorista, a high-quality capsule based on an “all-colorants” formulation. The new capsule further expands the Lonza Capsugel R&D offering.  Colorista capsules contain a broad selection of colorants suitable for use in major markets, allowing pharmaceutical customers to have access to a wide array of colors,…

Lonza holds grand opening for state-of-the-art drug product services labs. Lonza, a global leader in chemical and biological manufacturing, recently held the grand opening of its state-of-the-art pharmaceutical Drug Product Services laboratories in the Stücki Science Park Basel, Switzerland. Scientists in the new 1,300 square meter (14,000 square foot) facility will focus initially on formulation development, drug…